Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (51-60 of 387) with videos related to

Pageof 39
Sort By:
Leukemia Research|May 13, 2008
CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemiaSherine F Elsawa, Anne J Novak, Deanna Grote, et al.
International Journal of Cancer|July 17, 2003
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphomaJames R Cerhan, Kristin E Anderson, Carol A Janney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphomaWilliam G Martin, Kay M Ristow, Thomas M Habermann, et al.
Leukemia & Lymphoma|January 8, 2024
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphomaChonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, et al.
Haematologica|July 22, 2008
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, John A Lust, et al.
Case Reports in Hematology|November 14, 2013
Chronic Eosinophilic Leukemia-Not Otherwise Specified (NOS) in the Background of a Large Cell LymphomaWilson I Gonsalves, Rong He, Animesh Pardanani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapyMyron S Czuczman, Christos Emmanouilides, Mohamed Darif, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always InfectionGordon J Ruan, Sangeetha Gandhi, Jithma P Abeykoon, et al.
American Journal of Hematology|December 4, 2008
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphomaStephen M Ansell, Anne J Novak, Steven Ziesmer, et al.
Shock (Augusta, Ga.)|December 30, 2020
A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated CoagulopathyJulie Goswami, Taleen A MacArthur, Meera Sridharan, et al.
Pageof 39

Showing results (51-60 of 387) with videos related to

Sort By:
Pageof 39
Leukemia Research|May 13, 2008
CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemiaSherine F Elsawa, Anne J Novak, Deanna Grote, et al.
International Journal of Cancer|July 17, 2003
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphomaJames R Cerhan, Kristin E Anderson, Carol A Janney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphomaWilliam G Martin, Kay M Ristow, Thomas M Habermann, et al.
Leukemia & Lymphoma|January 8, 2024
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphomaChonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, et al.
Haematologica|July 22, 2008
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, John A Lust, et al.
Case Reports in Hematology|November 14, 2013
Chronic Eosinophilic Leukemia-Not Otherwise Specified (NOS) in the Background of a Large Cell LymphomaWilson I Gonsalves, Rong He, Animesh Pardanani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapyMyron S Czuczman, Christos Emmanouilides, Mohamed Darif, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always InfectionGordon J Ruan, Sangeetha Gandhi, Jithma P Abeykoon, et al.
American Journal of Hematology|December 4, 2008
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphomaStephen M Ansell, Anne J Novak, Steven Ziesmer, et al.
Shock (Augusta, Ga.)|December 30, 2020
A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated CoagulopathyJulie Goswami, Taleen A MacArthur, Meera Sridharan, et al.
Pageof 39